LightCPPgen: An Explainable Machine Learning Pipeline for Rational Design of Cell Penetrating Peptides

Read original: arXiv:2406.01617 - Published 6/5/2024 by Gabriele Maroni, Filip Stojceski, Lorenzo Pallante, Marco A. Deriu, Dario Piga, Gianvito Grasso
Total Score

0

🧠

Sign in to get full access

or

If you already have an account, we'll log you in

Overview

  • Cell-penetrating peptides (CPPs) are molecules that can transport therapeutic drugs into cells
  • Designing effective CPPs is challenging and requires extensive experimentation
  • This study introduces a novel approach called LightCPPgen that uses machine learning and optimization algorithms to streamline CPP design

Plain English Explanation

LightCPPgen is a new method for designing cell-penetrating peptides (CPPs) - molecules that can carry therapeutic drugs into cells. Designing effective CPPs is difficult and often requires a lot of trial-and-error experiments in the lab.

The researchers developed an approach that combines machine learning and optimization algorithms to generate and improve CPP designs more efficiently. At the core is a predictive model that can evaluate how well a CPP sequence will be able to enter cells, based on 20 different factors that influence this ability. This model works together with a genetic algorithm, which systematically tries out different CPP sequences and selects the most promising ones.

By using this computational approach, the researchers can identify the best CPP candidates without needing to make and test as many physical samples in the lab. This saves time and money. The model also provides insights into the key factors that make a CPP effective at entering cells, making the design process more understandable.

Overall, this research provides a robust framework that combines machine learning and optimization techniques to streamline the design of cell-penetrating peptides, with the goal of accelerating the development of new therapies.

Technical Explanation

The core of the LightCPPgen approach is a predictive model that can evaluate how well a given CPP sequence will be able to enter cells. This model is based on the LightGBM machine learning algorithm and utilizes 20 explainable features to understand the critical factors influencing CPP translocation capacity.

The predictive model works in tandem with a genetic algorithm (GA), an optimization technique that systematically generates and tests different CPP sequences. The GA is tuned to enhance computational efficiency while maintaining optimization performance. Specifically, the GA prioritizes maximizing the penetrability score of the candidate CPP sequences, while also trying to maintain similarity to the original non-penetrating peptide in order to preserve its original biological and physicochemical properties.

By integrating the machine learning model and the optimization algorithm, the LightCPPgen approach can substantially reduce the time and cost associated with wet lab experiments, as it allows for the prioritized synthesis of only the most promising CPP candidates. This framework contributes to the field of CPP design by enhancing the explainability and interpretability of the design process through the use of interpretable machine learning techniques.

Critical Analysis

The researchers acknowledge several limitations and areas for further research in their paper. For instance, they note that the current predictive model is trained on a relatively small dataset and may not generalize well to a broader range of CPP sequences and cell types. Additional experimental validation and model refinement would be needed to assess the robustness and broader applicability of the LightCPPgen approach.

Furthermore, while the interpretability of the model's features is a strength, the researchers do not delve deeply into the biological and mechanistic implications of the identified critical factors influencing CPP translocation. Additional research would be needed to fully understand the underlying mechanisms and potentially leverage this knowledge to further improve CPP design.

It would also be valuable to compare the performance of the LightCPPgen approach to other peptide design frameworks, such as those that utilize generative models or other optimization techniques, to assess its relative strengths and weaknesses.

Overall, the LightCPPgen method represents a promising step forward in the field of CPP design, but further research and validation will be necessary to fully realize its potential.

Conclusion

This study introduces LightCPPgen, an innovative approach that combines machine learning and optimization algorithms to facilitate the rational design of cell-penetrating peptides (CPPs). By developing an accurate and interpretable predictive model, as well as integrating it with an efficient optimization algorithm, the researchers have created a framework that can substantially reduce the time and cost associated with the development of new CPP-based therapies.

The key contributions of this work include the enhanced explainability and interpretability of the CPP design process, the systematic generation and optimization of promising CPP candidates, and the potential to accelerate the discovery and development of novel cell-penetrating peptides. As the field of CPP research continues to evolve, the LightCPPgen approach represents an important step towards more rational and efficient peptide design strategies.



This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!

Follow @aimodelsfyi on 𝕏 →

Related Papers

🧠

Total Score

0

LightCPPgen: An Explainable Machine Learning Pipeline for Rational Design of Cell Penetrating Peptides

Gabriele Maroni, Filip Stojceski, Lorenzo Pallante, Marco A. Deriu, Dario Piga, Gianvito Grasso

Cell-penetrating peptides (CPPs) are powerful vectors for the intracellular delivery of a diverse array of therapeutic molecules. Despite their potential, the rational design of CPPs remains a challenging task that often requires extensive experimental efforts and iterations. In this study, we introduce an innovative approach for the de novo design of CPPs, leveraging the strengths of machine learning (ML) and optimization algorithms. Our strategy, named LightCPPgen, integrates a LightGBM-based predictive model with a genetic algorithm (GA), enabling the systematic generation and optimization of CPP sequences. At the core of our methodology is the development of an accurate, efficient, and interpretable predictive model, which utilizes 20 explainable features to shed light on the critical factors influencing CPP translocation capacity. The CPP predictive model works synergistically with an optimization algorithm, which is tuned to enhance computational efficiency while maintaining optimization performance. The GA solutions specifically target the candidate sequences' penetrability score, while trying to maximize similarity with the original non-penetrating peptide in order to retain its original biological and physicochemical properties. By prioritizing the synthesis of only the most promising CPP candidates, LightCPPgen can drastically reduce the time and cost associated with wet lab experiments. In summary, our research makes a substantial contribution to the field of CPP design, offering a robust framework that combines ML and optimization techniques to facilitate the rational design of penetrating peptides, by enhancing the explainability and interpretability of the design process.

Read more

6/5/2024

Towards Evolutionary-based Automated Machine Learning for Small Molecule Pharmacokinetic Prediction
Total Score

0

Towards Evolutionary-based Automated Machine Learning for Small Molecule Pharmacokinetic Prediction

Alex G. C. de S'a, David B. Ascher

Machine learning (ML) is revolutionising drug discovery by expediting the prediction of small molecule properties essential for developing new drugs. These properties -- including absorption, distribution, metabolism and excretion (ADME)-- are crucial in the early stages of drug development since they provide an understanding of the course of the drug in the organism, i.e., the drug's pharmacokinetics. However, existing methods lack personalisation and rely on manually crafted ML algorithms or pipelines, which can introduce inefficiencies and biases into the process. To address these challenges, we propose a novel evolutionary-based automated ML method (AutoML) specifically designed for predicting small molecule properties, with a particular focus on pharmacokinetics. Leveraging the advantages of grammar-based genetic programming, our AutoML method streamlines the process by automatically selecting algorithms and designing predictive pipelines tailored to the particular characteristics of input molecular data. Results demonstrate AutoML's effectiveness in selecting diverse ML algorithms, resulting in comparable or even improved predictive performances compared to conventional approaches. By offering personalised ML-driven pipelines, our method promises to enhance small molecule research in drug discovery, providing researchers with a valuable tool for accelerating the development of novel therapeutic drugs.

Read more

8/2/2024

Topology-enhanced machine learning model (Top-ML) for anticancer peptide prediction
Total Score

0

Topology-enhanced machine learning model (Top-ML) for anticancer peptide prediction

Joshua Zhi En Tan, JunJie Wee, Xue Gong, Kelin Xia

Recently, therapeutic peptides have demonstrated great promise for cancer treatment. To explore powerful anticancer peptides, artificial intelligence (AI)-based approaches have been developed to systematically screen potential candidates. However, the lack of efficient featurization of peptides has become a bottleneck for these machine-learning models. In this paper, we propose a topology-enhanced machine learning model (Top-ML) for anticancer peptide prediction. Our Top-ML employs peptide topological features derived from its sequence connection information characterized by vector and spectral descriptors. Our Top-ML model has been validated on two widely used AntiCP 2.0 benchmark datasets and has achieved state-of-the-art performance. Our results highlight the potential of leveraging novel topology-based featurization to accelerate the identification of anticancer peptides.

Read more

7/15/2024

Exploring Latent Space for Generating Peptide Analogs Using Protein Language Models
Total Score

0

Exploring Latent Space for Generating Peptide Analogs Using Protein Language Models

Po-Yu Liang, Xueting Huang, Tibo Duran, Andrew J. Wiemer, Jun Bai

Generating peptides with desired properties is crucial for drug discovery and biotechnology. Traditional sequence-based and structure-based methods often require extensive datasets, which limits their effectiveness. In this study, we proposed a novel method that utilized autoencoder shaped models to explore the protein embedding space, and generate novel peptide analogs by leveraging protein language models. The proposed method requires only a single sequence of interest, avoiding the need for large datasets. Our results show significant improvements over baseline models in similarity indicators of peptide structures, descriptors and bioactivities. The proposed method validated through Molecular Dynamics simulations on TIGIT inhibitors, demonstrates that our method produces peptide analogs with similar yet distinct properties, highlighting its potential to enhance peptide screening processes.

Read more

8/19/2024